Cabozantinib ameliorates lipopolysaccharide-induced lung inflammation and bleomycin--induced early pulmonary fibrosis in mice
Xiaohe Li, Ling Ma, Yuli Wei, Jinying Gu, Jingjing Liang, Shimeng Li, Yunyao Cui, Rui Liu, Hui Huang, Cheng Yang, Honggang Zhou
Topics & Concepts
Pulmonary fibrosisBleomycinMedicineLungCabozantinibFibrosisCancer researchIdiopathic pulmonary fibrosisPathologyInternal medicineChemotherapyVEGF receptorsInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisHistiocytic Disorders and TreatmentsLung Cancer Treatments and Mutations